Globe Newswire
Transgene and University of Copenhagen are collaborating on the investigator-sponsored OV-PRIME-R trial evaluating armed oncolytic virus BT-001 combined with an anti-PD1 in patients with localized rectal cancer with proficient mismatch repair status1
Strasbourg, France, November 5, 2026, 8:00 a.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer and Bispebjerg and Frederiksberg... (continue reading...)
LONDON, Nov. 05, 2026 (GLOBE NEWSWIRE) --
WHAT:
Beyond Participation: Can Employee Equity Build Lifelong Investors?
As the UK looks to reinvigorate its retail investment culture, Equiniti is bringing together senior voices from banking, investment management and employee share plans to tackle an important question: can becoming a shareholder at work be the start of a lifelong investment journey?
WHY:
Employee share plans put investing directly within reach of... (continue reading...)
Transgene and University of Copenhagen are collaborating on the investigator-sponsored OV-PRIME-R trial evaluating armed oncolytic virus BT-001 combined with an anti-PD1 in patients with localized rectal cancer with proficient mismatch repair status1
Strasbourg, France, November 5, 2026, 8:00 a.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer and Bispebjerg and Frederiksberg... (continue reading...)
Sales Revenues and Profitability
Eesti Energia Group's sales revenue in Q3 2026 totalled EUR 389 million, a 38% increase year-on-year. Group EBITDA more than doubled to EUR 60 million (Q3 2025: EUR 28 million). The Group earned a net profit of EUR 1.6 million, compared with a net loss of EUR 66.0 million in Q3 2025, which included an impairment of shale oil production assets of EUR 39.0 million. For the first nine months of 2026, sales revenue increased by 12% to EUR... (continue reading...)
OSB GROUP PLC Announces Cash Tender Offers for its £300,000,000 Fixed Rate Resetting Notes due 7 September 2028 and £400,000,000 Fixed Rate Resetting Notes due 16 January 2030
THIS ANNOUNCEMENT RELATES TO THE DISCLOSURE OF INFORMATION THAT QUALIFIED OR MAY HAVE QUALIFIED AS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 (the EUWA).
More Globe Newswire
View Older Stories-
Notice of Q3 2026 Results and Webcast Details
-
OSB GROUP PLC - Trading update for the nine months to 30 September 2026
-
NBPE Announces Transaction in Own Shares
-
T-Therapeutics announces oversubscribed $133 million Series B financing to achieve clinical proof-of-concept for first-in-class TCR bispecific therapies in cancer and autoimmune disease
-
Suominen Corporation’s Interim Report for January 1–September 30, 2026: Continued performance improvement in the third quarter
-
Major Shareholder Announcement
-
Interim report 9M 2026
-
Air France-KLM Q3 2026 Results
-
Interim Report Q3 2026
-
Upgrade of guidance for full year 2026
-
AL Sydbank delivers best quarterly performance and raises its expectations
-
AL Sydbank A/S to revise its expectations upwards as regards profit for 2026
-
New report: Small EU rule change could unlock 9.3 billion euros in investments for circular phosphorus production
-
Satisfactory Q3 result in special circumstances – capital adequacy continued to strengthen
-
ANI Pharmaceuticals Announces Offer to Acquire Egetis Therapeutics, Expanding the Scope and Scale of Its Rare Disease Business
-
Civinity AB continues its note programme: a new tranche of the note issue worth up to EUR 8,000,000, intended to finance the Group’s further expansion
-
Bouygues: Very strong nine-month 2026 Group results, Group full-year COPA now expected to increase slightly
-
Baltic Horizon Fund publishes interest rate applicable to the bonds for the next interest period
-
EfTEN United Property Fund unaudited financial results for 3rd quarter and 9 months of 2026
-
2026 9 months and III quarter consolidated unaudited interim report
-
Vivoryon Therapeutics N.V. Reports Q3 2026 Financial Results and Provides Business Update
-
FTI Consulting Appoints Aurélien Louis to Build on Transactions Capabilities in France
-
Siemens Healthineers to Rebrand In Vitro Diagnostics Business as Olyrian Diagnostics
-
Syensqo third quarter 2026 results
-
IMCD reports EBITA of EUR 425 million (+8%) in the first nine months of 2026
-
ForFarmers N.V.: Trading update Q3 2026
-
ArcelorMittal reports third quarter 2026 results
-
Start of Day Message
-
2026 III quarter and 9 months consolidated interim report (unaudited)
-
IBA signs contract with the Government of Assam for India’s First State-run Proton Therapy Center
-
WISeQey Advances PKI Modernization as Recent Cyberattacks Highlight the Need to Limit Identity and Credential Risks
-
Molecular Partners to Present on DLL3-Targeting Radio-DARPin MP0712 at 2026 SNMMI Theranostics Conference and NACLC 2026
-
NORBIT - Invitation to presentation of NORBIT's third quarter results, 12 November 2026
-
Zelluna ASA: Third Quarter 2026 results
-
Interim Report for Q3 2026
-
VGP NV: Trading Update
-
Q3 2026 Update: Tecan reports acceleration of sales growth in Q3 and raises full-year 2026 outlook
-
Lumo Homes Plc: Lumo Homes plc’s Interim Report 1 January–30 September 2026
-
Bekaert to acquire Dextra, a leading provider of sustainable construction reinforcement solutions
-
Interim Report Q3 2026: Successful product launches leading to 2% organic revenue growth and margin expansion
-
Wood Mackenzie: One in five refineries at closure risk as global oil demand peaks in 2032
-
TTAN Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud Against ServiceTitan, Inc.
-
Financial institutions accelerate transition to multi-agent AI in drive for bottom-line value
-
DOX Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud Against Amdocs Limited
-
2026 Results of Annual General Meeting
-
DeFi Technologies Announces Shareholder Call to Discuss Q3 2026 Financial Results
-
Cardinal Point Wealth Management Highlights Estate Planning Considerations for Canadians with U.S. Assets
-
Fortuna Reports Results for the Third Quarter 2026
-
From Individual Upgrades to a Complete Workstation: Four Home Office Setup Ideas from Eureka Ergonomic
-
3D Systems Announces Agreements to Exchange All Outstanding 5.875% Convertible Senior Secured Notes Due 2030, Eliminating All Secured Debt
